Archive for the ‘Biotechnology’ Category
Wednesday, April 7th, 2010
Nanoscience gets funding
New Jobs in Irish Nanoscience Research?
Nanoscience research institute CRANN is to create new jobs in Research & Development, leading research projects including cancer research and computer chips.
The majority of these seventeen newly created positions are to be in the Institute of Molecular Medicine and TCD School of Medicine in conjunction with CRANN. This particular team will be aiming at nanomedical technology in the early diagnosis of cancer.
The remaining 5 positions are to be with Intel as CRANN focuses on developing computer chips for the next generation.
Professor John Boland, Director of CRANN says “Ireland is now globally recognised for it’s expertise in the area of nanoscience, as evidenced by the large amounts of non-exchequer funding we are winning through competitive international research projects.” He goes on to say “Research is a global competition and we need to contuinue to develop our knowledge base and expertise to make Ireland a true innovation centre”
The investment was seen as a “huge vote of confidence” by Professor Dermot Kelleher of TCD School of Medicine.
Tags: development, irish nanoscience, Nanoscience, nanoscience funding, nanoscience jobs, R&D, R&D Jobs, research, research & development, research & development jobs, research jobs, Science, science jobs
Posted in Biotechnology, Computer Science, Nano Devices, Nanotechnology, R&D, Research and Development, science jobs, semiconductors | No Comments »
Friday, March 12th, 2010
Chief Science Officers come from a variety of Science backrounds including Pharmacy
Science Officers Lead The Way in Irelands start up and established Pharmaceutical R&D companies. They provide the scientific backbone of R&D, Regulatory affairs and Pharmacovigilence activity where insight and understanding go hand in hand.
A typical Chief Science Officer will manage and administer the actvities of other medical drug safety officers, science officers and technical personnel involved first hand in project engineering and the management of other scientists who may also be Pharmacists engaged in the introduction of new drugs which will also involve vigilence reporting and monitoring of ADR’s and PSUR’s.
Irish Pharmaceutical enterprises are highly engaged in the latest Pharmaceutical drug research and development and it is through the technical and scientific know how of science officers that Ireland has gained significant FDI (Foreign Direct Investment)
Eight out of ten major internationla biopharma and pharmaceutical multinationals have now sited here in Ireland and this is showing no sign of slowing yet despite the economic downturn.
Tags: ADR's, biopharma, Chief Science Officer, established Pharmaceutical R&D companies, FDI, Irelands start up companies, management, medical drug safety officer, monitoring, my science jobs, Project Engineer, PSUR's, Regulatory Affairs, Science officers, scientific, Scientists, vigilence reporting
Posted in Biotechnology, Life Sciences, R&D | No Comments »
Monday, January 4th, 2010
Biopharma R&D
R&D Continues to expand with several major projecst on the cards for Intel, Pfizer and UCD. Major projects involving nanotechnology, Biopharma and Semiconductor manufacturing facilities in Ireland will continue the extensive developments which have taken place in the past five years.
Ireland continues to lead R&D in numerous sectors including advanced manufacturing on medical device products and as a result science jobs will be in demand across various life science sectors such as QA/RA, Validation, R&D and drug product developments.
Ireland with the backing of major multinational clients such as Intel, Pfizer and Abbotts will be a continuing center of excellence in science and technology as a result and this will be a primary driver in Irelands emergence from recession
Posted in Biotechnology, Genetics, Life Sciences | No Comments »
Monday, November 2nd, 2009
3- 5 years from Killing Cancer
Killing Leukaemia has been the objective of Cancer Research Scientists for decades. Today that objective has come a step closer with the announcement in the international journal, Cancer Research , that TCD in partnership with the University of Sienna have discovered a new drug called PBOX-15 capable of killing cancerous cells in adult patients with poor prognosis.
R&D is still at an early stage however with development of a viable drug between 3- 5 years from being produced according to Professor Mark Lawlor of TCD’S school of medicine. The study itself involved research across the disciplines of molecular, chemistry and biochemistry at TCD together with contributions from Research colleagues in Belfast City Hospital, Siennna and St James Hospital Dublin.
Tags: academic research, Belfast City Hospital, Biochemistry Research, Cancer Research, Drug research, Hospital, Leukaemia, Molecular Biology, R&D, Research and Development, Scientific Research, Scientists, Sienna University, St James Hospital, TCD R&D, Trinity College Dublin, University
Posted in Biotechnology, Diagnostic Medicine, Life Sciences | No Comments »
Monday, October 19th, 2009
R&D- the $68 Billion Dollar Question. Today Pfizer begins the arduous process of choosing which of its R&D plants will be closed following completion of its successful buy out of Wyeth. Pfizer has 30 -60 days to complete this review review according to its chief financial officer.
Pfizer completes its takeover of Wyeth
Pfizer’s total Irish investment amounts to over €7 Billion with products as diverse as vaccines, biologics, nutrition and small molecules, and catering for both animal and human healthcare product sectors. The current combined workforce amounts to over 5000 people but this may be somewhat reduced following the conclusion of the review process which will lead to reductions in R&D, Engineering and support staff.
However, Pfizer has a significant pipe line of biopharmaceutical development products incoporating exploratory treatments for Alzheimers, Diabetes, inflamation and neuroscience.
The vast majority of these conditions are unmet medical conditions which have potentially longterm and lucrative treatment markets and as such hold the promise of long term future investment in Irish science jobs.
Posted in Biotechnology, Pharmaceuticals, R&D | No Comments »
